| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 1.76e-11 | 5 | 143 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 1.05e-10 | 6 | 143 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | calcium ion binding | AMY1A AMY1B AMY1C AMY2A AMY2B MYL6 PCDHB13 APCS CUBN VWCE KCNIP2 CRELD1 NELL2 MAN1A2 HMCN1 SUSD1 OTOF MYL6B SCUBE3 C1R KCNIP4 REPS2 HSPA5 ALPL | 6.87e-10 | 749 | 143 | 24 | GO:0005509 |
| GeneOntologyMolecularFunction | chloride ion binding | 7.20e-08 | 16 | 143 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | galactoside binding | 3.09e-07 | 9 | 143 | 4 | GO:0016936 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 9.31e-06 | 103 | 143 | 7 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 9.42e-06 | 144 | 143 | 8 | GO:0016798 | |
| GeneOntologyMolecularFunction | disaccharide binding | 1.23e-05 | 7 | 143 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | C-acyltransferase activity | 1.37e-05 | 21 | 143 | 4 | GO:0016408 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.27e-05 | 118 | 143 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF13B ABCA2 ERCC2 MYL6 DNAH10 ATP8A2 ACSM1 ACSM3 KIFC3 KIF13A DNAH5 HSPA5 VCP ALPL | 1.35e-04 | 614 | 143 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.46e-04 | 70 | 143 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.71e-04 | 18 | 143 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | BAT3 complex binding | 3.03e-04 | 4 | 143 | 2 | GO:1904288 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 3.75e-04 | 20 | 143 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | heparin binding | 4.74e-04 | 192 | 143 | 7 | GO:0008201 | |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 9.27e-04 | 27 | 143 | 3 | GO:0017134 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF13B ABCA2 ERCC2 DNAH10 ATP8A2 KIF13A DNAH5 HSPA5 VCP ALPL | 1.31e-03 | 441 | 143 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | fatty-acyl-CoA synthase activity | 1.39e-03 | 8 | 143 | 2 | GO:0004321 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 1.33e-06 | 4 | 144 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 5.05e-06 | 17 | 144 | 4 | GO:0043301 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 5.11e-06 | 63 | 144 | 6 | GO:0007157 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | LGALS9C CFH CNTN4 IL12B SDK2 ZAN CD244 LGALS9B WNT5A PKD1L1 PCDHB13 COLEC10 LGALS9 HMCN1 ZFP36L1 PTPRS ICAM5 CNTN5 NECTIN4 KIRREL1 LOXL3 KIFC3 | 5.66e-06 | 1077 | 144 | 22 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 1.01e-05 | 20 | 144 | 4 | GO:0010819 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 1.07e-05 | 42 | 144 | 5 | GO:0002323 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | LGALS9C CNTN4 SDK2 LGALS9B PCDHB13 COLEC10 LGALS9 HMCN1 PTPRS CNTN5 NECTIN4 | 1.29e-05 | 313 | 144 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.63e-05 | 115 | 144 | 7 | GO:0090100 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 1.82e-05 | 8 | 144 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 1.87e-05 | 47 | 144 | 5 | GO:2000316 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 2.74e-05 | 171 | 144 | 8 | GO:0048593 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell proliferation | 3.39e-05 | 53 | 144 | 5 | GO:0046640 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell proliferation | 5.72e-05 | 59 | 144 | 5 | GO:0046633 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 6.19e-05 | 31 | 144 | 4 | GO:1901623 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 6.72e-05 | 61 | 144 | 5 | GO:0032814 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 7.04e-05 | 32 | 144 | 4 | GO:1903306 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 7.97e-05 | 33 | 144 | 4 | GO:0010818 | |
| GeneOntologyBiologicalProcess | T-helper 17 type immune response | 8.47e-05 | 64 | 144 | 5 | GO:0072538 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 9.52e-05 | 204 | 144 | 8 | GO:0048592 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 1.43e-04 | 15 | 144 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 1.43e-04 | 15 | 144 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | response to growth factor | GPC1 ROCK2 LGALS9C IL12B LGALS9B WNT5A KCP ACVRL1 LGALS9 TH ZFP36L1 GLG1 FURIN SCUBE3 FGFR3 HSPA5 DNMT1 | 1.47e-04 | 883 | 144 | 17 | GO:0070848 |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | ROCK2 LGALS9C LGALS9B ACVRL1 LGALS9 ZFP36L1 GLG1 FURIN HSPA5 DNMT1 | 1.52e-04 | 343 | 144 | 10 | GO:0071559 |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | LGALS9C LGALS9B WNT5A KCP ACVRL1 LGALS9 GLG1 FURIN SCUBE3 HSPA5 | 1.67e-04 | 347 | 144 | 10 | GO:0090092 |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell activation | 1.71e-04 | 40 | 144 | 4 | GO:2000515 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell migration | 1.89e-04 | 41 | 144 | 4 | GO:2000406 | |
| GeneOntologyBiologicalProcess | negative regulation of smoothened signaling pathway | 2.08e-04 | 42 | 144 | 4 | GO:0045879 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 2.08e-04 | 42 | 144 | 4 | GO:0043032 | |
| GeneOntologyBiologicalProcess | positive regulation of SMAD protein signal transduction | 2.28e-04 | 43 | 144 | 4 | GO:0060391 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 2.52e-04 | 18 | 144 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 2.59e-04 | 81 | 144 | 5 | GO:0043030 | |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 2.72e-04 | 45 | 144 | 4 | GO:0045920 | |
| GeneOntologyBiologicalProcess | cytokine precursor processing | 2.88e-04 | 4 | 144 | 2 | GO:0140447 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 2.98e-04 | 19 | 144 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell apoptotic process | 2.98e-04 | 19 | 144 | 3 | GO:0070234 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 2.98e-04 | 19 | 144 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | GPC1 LGALS9C IL12B LGALS9B WNT5A KCP ACVRL1 LGALS9 TH ZFP36L1 GLG1 FURIN SCUBE3 FGFR3 HSPA5 DNMT1 | 3.00e-04 | 850 | 144 | 16 | GO:0071363 |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-10 production | 3.49e-04 | 48 | 144 | 4 | GO:0032733 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte migration | 3.78e-04 | 49 | 144 | 4 | GO:2000403 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-1 production | 3.81e-04 | 88 | 144 | 5 | GO:0032732 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 4.04e-04 | 21 | 144 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell activation | 4.72e-04 | 141 | 144 | 6 | GO:0046634 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell activation | 4.76e-04 | 52 | 144 | 4 | GO:0046636 | |
| GeneOntologyBiologicalProcess | lymphocyte chemotaxis | 5.12e-04 | 53 | 144 | 4 | GO:0048247 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 5.88e-04 | 147 | 144 | 6 | GO:0031341 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | LGALS9C LGALS9B ACVRL1 LGALS9 ZFP36L1 GLG1 FURIN HSPA5 DNMT1 | 6.02e-04 | 336 | 144 | 9 | GO:0071560 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte apoptotic process | 6.06e-04 | 24 | 144 | 3 | GO:0070230 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | AMY1A AMY1B AMY1C AMY2A AMY2B CD244 NANP RPIA GK2 MAN1A2 GLA P2RX7 NISCH | 6.10e-04 | 646 | 144 | 13 | GO:0005975 |
| GeneOntologyBiologicalProcess | regulation of T cell migration | 6.31e-04 | 56 | 144 | 4 | GO:2000404 | |
| GeneOntologyBiologicalProcess | central nervous system development | CNTN4 AARS1 ABCA2 ERCC2 WNT5A ROR1 C12orf57 TMX2 TH PTPRS CNTN5 ZNF76 IFT122 FGFR3 LOXL3 HERC1 NRG3 DNAH5 HSPA5 | 6.77e-04 | 1197 | 144 | 19 | GO:0007417 |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell activation | 6.84e-04 | 100 | 144 | 5 | GO:2000514 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | LGALS9C CFH IL12B IL13RA2 CD244 LGALS9B WNT5A COLEC10 LGALS9 P2RX7 LOXL3 | 7.48e-04 | 497 | 144 | 11 | GO:0002697 |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 7.70e-04 | 26 | 144 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | regulation of type II interferon production | 7.77e-04 | 155 | 144 | 6 | GO:0032649 | |
| GeneOntologyCellularComponent | extracellular matrix | GPC1 LGALS9C COL11A2 ZAN LGALS9B WNT5A APCS MUC5B LGALS9 CRELD1 FCGBP HMCN1 GLG1 ADAMTS15 LOXL3 HCFC1 ALPL | 2.88e-06 | 656 | 144 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | GPC1 LGALS9C COL11A2 ZAN LGALS9B WNT5A APCS MUC5B LGALS9 CRELD1 FCGBP HMCN1 GLG1 ADAMTS15 LOXL3 HCFC1 ALPL | 3.00e-06 | 658 | 144 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | Golgi lumen | 1.09e-04 | 109 | 144 | 6 | GO:0005796 | |
| GeneOntologyCellularComponent | cell surface | GPC1 CFH IL12B IL13RA2 CD244 WNT5A ROR1 COLEC10 CUBN ACVRL1 VWDE TFPI P2RX7 FURIN ADAMTS15 SCUBE3 CD79B FGFR3 HSPA5 | 2.29e-04 | 1111 | 144 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | GPC1 LGALS9C COL11A2 LGALS9B WNT5A APCS LGALS9 CRELD1 HMCN1 ADAMTS15 LOXL3 HCFC1 | 3.12e-04 | 530 | 144 | 12 | GO:0062023 |
| Domain | Alpha_amylase | 3.20e-09 | 4 | 142 | 4 | IPR006046 | |
| Domain | Aamy_C | 3.20e-09 | 4 | 142 | 4 | SM00632 | |
| Domain | VWC_out | 4.34e-09 | 19 | 142 | 6 | SM00215 | |
| Domain | EGF-like_dom | PCSK5 ZAN CUBN VWCE ADAM12 VWDE CRELD1 NELL2 FCGBP HMCN1 SUSD1 SCUBE3 C1R NRG3 | 6.86e-09 | 249 | 142 | 14 | IPR000742 |
| Domain | Alpha-amylase_C | 1.59e-08 | 5 | 142 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 1.59e-08 | 5 | 142 | 4 | IPR006048 | |
| Domain | EGF | PCSK5 ZAN CUBN VWCE VWDE CRELD1 NELL2 FCGBP HMCN1 SUSD1 SCUBE3 C1R NRG3 | 2.95e-08 | 235 | 142 | 13 | SM00181 |
| Domain | Glyco_hydro_b | 6.69e-08 | 15 | 142 | 5 | IPR013780 | |
| Domain | VWF_type-D | 9.67e-08 | 16 | 142 | 5 | IPR001846 | |
| Domain | VWFD | 9.67e-08 | 16 | 142 | 5 | PS51233 | |
| Domain | VWD | 9.67e-08 | 16 | 142 | 5 | SM00216 | |
| Domain | VWD | 9.67e-08 | 16 | 142 | 5 | PF00094 | |
| Domain | Glyco_hydro_13_cat_dom | 1.10e-07 | 7 | 142 | 4 | IPR006047 | |
| Domain | Alpha-amylase | 1.10e-07 | 7 | 142 | 4 | PF00128 | |
| Domain | Aamy | 1.10e-07 | 7 | 142 | 4 | SM00642 | |
| Domain | EGF_3 | ZAN CUBN VWCE ADAM12 VWDE CRELD1 NELL2 HMCN1 SUSD1 SCUBE3 C1R NRG3 | 2.45e-07 | 235 | 142 | 12 | PS50026 |
| Domain | EGF_CA | 2.95e-07 | 86 | 142 | 8 | PF07645 | |
| Domain | Growth_fac_rcpt_ | 3.20e-07 | 156 | 142 | 10 | IPR009030 | |
| Domain | VWC | 3.93e-07 | 38 | 142 | 6 | SM00214 | |
| Domain | A-amylase_C | 4.30e-07 | 3 | 142 | 3 | IPR031319 | |
| Domain | EGF_1 | ZAN CUBN VWCE ADAM12 VWDE CRELD1 NELL2 HMCN1 SUSD1 SCUBE3 C1R NRG3 | 5.87e-07 | 255 | 142 | 12 | PS00022 |
| Domain | VWF_dom | 7.27e-07 | 42 | 142 | 6 | IPR001007 | |
| Domain | EGF_Ca-bd_CS | 7.49e-07 | 97 | 142 | 8 | IPR018097 | |
| Domain | EGF-like_CS | ZAN CUBN VWCE ADAM12 VWDE CRELD1 NELL2 HMCN1 SUSD1 SCUBE3 C1R NRG3 | 7.51e-07 | 261 | 142 | 12 | IPR013032 |
| Domain | EGF_CA | 8.76e-07 | 99 | 142 | 8 | PS01187 | |
| Domain | EGF_2 | ZAN CUBN VWCE ADAM12 VWDE CRELD1 NELL2 HMCN1 SUSD1 SCUBE3 C1R NRG3 | 8.82e-07 | 265 | 142 | 12 | PS01186 |
| Domain | ASX_HYDROXYL | 9.46e-07 | 100 | 142 | 8 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.47e-06 | 106 | 142 | 8 | IPR000152 | |
| Domain | IGc2 | CNTN4 IL12B SDK2 ROR1 HMCN1 PTPRS ICAM5 CNTN5 NECTIN4 KIRREL1 FGFR3 | 1.86e-06 | 235 | 142 | 11 | SM00408 |
| Domain | Ig_sub2 | CNTN4 IL12B SDK2 ROR1 HMCN1 PTPRS ICAM5 CNTN5 NECTIN4 KIRREL1 FGFR3 | 1.86e-06 | 235 | 142 | 11 | IPR003598 |
| Domain | Unchr_dom_Cys-rich | 2.17e-06 | 13 | 142 | 4 | IPR014853 | |
| Domain | C8 | 2.17e-06 | 13 | 142 | 4 | SM00832 | |
| Domain | TIL_dom | 3.02e-06 | 14 | 142 | 4 | IPR002919 | |
| Domain | - | 3.02e-06 | 14 | 142 | 4 | 2.60.40.1180 | |
| Domain | EGF_CA | 4.25e-06 | 122 | 142 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.80e-06 | 124 | 142 | 8 | IPR001881 | |
| Domain | ConA-like_dom | LGALS9C COL11A2 ZAN LGALS9B APCS LGALS9 NELL2 TRIM67 HERC1 RNF39 | 6.91e-06 | 219 | 142 | 10 | IPR013320 |
| Domain | VWFC_1 | 7.38e-06 | 36 | 142 | 5 | PS01208 | |
| Domain | Glyco_hydro_13 | 8.46e-06 | 6 | 142 | 3 | IPR015902 | |
| Domain | Furin_repeat | 9.02e-06 | 18 | 142 | 4 | IPR006212 | |
| Domain | FU | 9.02e-06 | 18 | 142 | 4 | SM00261 | |
| Domain | VWFC_2 | 9.71e-06 | 38 | 142 | 5 | PS50184 | |
| Domain | Ig_I-set | 1.51e-05 | 190 | 142 | 9 | IPR013098 | |
| Domain | I-set | 1.51e-05 | 190 | 142 | 9 | PF07679 | |
| Domain | CUB | 3.45e-05 | 49 | 142 | 5 | PF00431 | |
| Domain | CUB | 3.81e-05 | 50 | 142 | 5 | SM00042 | |
| Domain | - | CNTN4 IL12B IL13RA2 SDK2 CD244 ROR1 TRIM67 HMCN1 PTPRS ICAM5 CNTN5 NECTIN4 KIRREL1 CD79B FGFR3 HCFC1 | 4.53e-05 | 663 | 142 | 16 | 2.60.40.10 |
| Domain | - | 4.62e-05 | 52 | 142 | 5 | 2.60.120.290 | |
| Domain | CUB | 5.07e-05 | 53 | 142 | 5 | PS01180 | |
| Domain | Glycoside_hydrolase_SF | 5.07e-05 | 53 | 142 | 5 | IPR017853 | |
| Domain | VWC | 5.69e-05 | 28 | 142 | 4 | PF00093 | |
| Domain | CUB_dom | 7.21e-05 | 57 | 142 | 5 | IPR000859 | |
| Domain | - | 8.66e-05 | 95 | 142 | 6 | 2.60.120.200 | |
| Domain | C8 | 9.00e-05 | 12 | 142 | 3 | PF08742 | |
| Domain | TIL | 9.00e-05 | 12 | 142 | 3 | PF01826 | |
| Domain | IG | CNTN4 SDK2 CD244 ROR1 HMCN1 PTPRS ICAM5 CNTN5 NECTIN4 KIRREL1 CD79B FGFR3 | 9.14e-05 | 421 | 142 | 12 | SM00409 |
| Domain | Ig_sub | CNTN4 SDK2 CD244 ROR1 HMCN1 PTPRS ICAM5 CNTN5 NECTIN4 KIRREL1 CD79B FGFR3 | 9.14e-05 | 421 | 142 | 12 | IPR003599 |
| Domain | Ig-like_fold | CNTN4 IL12B IL13RA2 SDK2 CD244 ROR1 TRIM67 HMCN1 PTPRS ICAM5 CNTN5 NECTIN4 KIRREL1 CD79B FGFR3 HCFC1 | 9.49e-05 | 706 | 142 | 16 | IPR013783 |
| Domain | IG_LIKE | CNTN4 IL12B SDK2 CD244 ROR1 HMCN1 PTPRS ICAM5 CNTN5 NECTIN4 KIRREL1 CD79B FGFR3 | 9.74e-05 | 491 | 142 | 13 | PS50835 |
| Domain | ig | 1.04e-04 | 190 | 142 | 8 | PF00047 | |
| Domain | Immunoglobulin | 1.04e-04 | 190 | 142 | 8 | IPR013151 | |
| Domain | Ig-like_dom | CNTN4 IL12B SDK2 CD244 ROR1 HMCN1 PTPRS ICAM5 CNTN5 NECTIN4 KIRREL1 CD79B FGFR3 | 1.24e-04 | 503 | 142 | 13 | IPR007110 |
| Domain | FN3 | 1.43e-04 | 199 | 142 | 8 | PS50853 | |
| Domain | TILa_dom | 1.71e-04 | 3 | 142 | 2 | IPR025615 | |
| Domain | TILa | 1.71e-04 | 3 | 142 | 2 | PF12714 | |
| Domain | Galectin_CRD | 1.83e-04 | 15 | 142 | 3 | IPR001079 | |
| Domain | Gal-bind_lectin | 1.83e-04 | 15 | 142 | 3 | PF00337 | |
| Domain | Gal-bind_lectin | 1.83e-04 | 15 | 142 | 3 | SM00908 | |
| Domain | GALECTIN | 1.83e-04 | 15 | 142 | 3 | PS51304 | |
| Domain | GLECT | 1.83e-04 | 15 | 142 | 3 | SM00276 | |
| Domain | Glyco_hydro_catalytic_dom | 1.93e-04 | 38 | 142 | 4 | IPR013781 | |
| Domain | FN3_dom | 2.00e-04 | 209 | 142 | 8 | IPR003961 | |
| Domain | Kinesin-like_KIF1-typ | 3.41e-04 | 4 | 142 | 2 | IPR022140 | |
| Domain | KIF1B | 3.41e-04 | 4 | 142 | 2 | PF12423 | |
| Domain | RCC1 | 4.46e-04 | 20 | 142 | 3 | PF00415 | |
| Domain | RCC1_1 | 5.18e-04 | 21 | 142 | 3 | PS00625 | |
| Domain | RCC1_2 | 5.18e-04 | 21 | 142 | 3 | PS00626 | |
| Domain | RCC1_3 | 5.18e-04 | 21 | 142 | 3 | PS50012 | |
| Domain | - | 5.96e-04 | 22 | 142 | 3 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 5.96e-04 | 22 | 142 | 3 | IPR000408 | |
| Domain | Sushi | 6.53e-04 | 52 | 142 | 4 | PF00084 | |
| Domain | RCC1/BLIP-II | 6.82e-04 | 23 | 142 | 3 | IPR009091 | |
| Domain | CCP | 7.54e-04 | 54 | 142 | 4 | SM00032 | |
| Domain | Kinesin_assoc | 8.44e-04 | 6 | 142 | 2 | PF16183 | |
| Domain | Peptidase_S8_Asp-AS | 8.44e-04 | 6 | 142 | 2 | IPR023827 | |
| Domain | Kinesin-like | 8.44e-04 | 6 | 142 | 2 | IPR022164 | |
| Domain | Kinesin_assoc | 8.44e-04 | 6 | 142 | 2 | IPR032405 | |
| Domain | DUF3694 | 8.44e-04 | 6 | 142 | 2 | PF12473 | |
| Domain | SUSHI | 8.66e-04 | 56 | 142 | 4 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 9.26e-04 | 57 | 142 | 4 | IPR000436 | |
| Domain | PKD | 1.18e-03 | 7 | 142 | 2 | PF00801 | |
| Domain | P_proprotein | 1.18e-03 | 7 | 142 | 2 | PF01483 | |
| Domain | S8_pro-domain | 1.18e-03 | 7 | 142 | 2 | IPR032815 | |
| Domain | PrprotnconvertsP | 1.18e-03 | 7 | 142 | 2 | IPR002884 | |
| Domain | - | 1.18e-03 | 7 | 142 | 2 | 3.30.70.850 | |
| Domain | S8_pro-domain | 1.18e-03 | 7 | 142 | 2 | PF16470 | |
| Domain | fn3 | 1.51e-03 | 162 | 142 | 6 | PF00041 | |
| Domain | TSP1 | 1.51e-03 | 65 | 142 | 4 | SM00209 | |
| Domain | TSP1_rpt | 1.51e-03 | 65 | 142 | 4 | IPR000884 | |
| Domain | TSP1 | 1.51e-03 | 65 | 142 | 4 | PS50092 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 3.89e-09 | 9 | 114 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.41e-08 | 11 | 114 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 9.49e-07 | 23 | 114 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 2.68e-06 | 28 | 114 | 5 | M27837 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 2.80e-05 | 8 | 114 | 3 | MM14717 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 6.08e-05 | 52 | 114 | 5 | M14171 | |
| Pathway | REACTOME_EARLY_SARS_COV_2_INFECTION_EVENTS | 2.18e-04 | 37 | 114 | 4 | M45028 | |
| Pubmed | 7.03e-12 | 6 | 145 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 7.03e-12 | 6 | 145 | 5 | 2788608 | |
| Pubmed | 7.03e-12 | 6 | 145 | 5 | 15286789 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 7.03e-12 | 6 | 145 | 5 | 6608795 | |
| Pubmed | 7.03e-12 | 6 | 145 | 5 | 2081604 | ||
| Pubmed | 6.52e-11 | 8 | 145 | 5 | 12414807 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 2.90e-10 | 4 | 145 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 2.90e-10 | 4 | 145 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 2.90e-10 | 4 | 145 | 4 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 2.90e-10 | 4 | 145 | 4 | 26098870 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 2.90e-10 | 4 | 145 | 4 | 4745489 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 2.90e-10 | 4 | 145 | 4 | 94264 | |
| Pubmed | 2.90e-10 | 4 | 145 | 4 | 3872721 | ||
| Pubmed | 2.90e-10 | 4 | 145 | 4 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 2.90e-10 | 4 | 145 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 2.90e-10 | 4 | 145 | 4 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 2.90e-10 | 4 | 145 | 4 | 2987507 | |
| Pubmed | 2.90e-10 | 4 | 145 | 4 | 6091898 | ||
| Pubmed | 2.90e-10 | 4 | 145 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 2.90e-10 | 4 | 145 | 4 | 6162108 | |
| Pubmed | 2.90e-10 | 4 | 145 | 4 | 16152770 | ||
| Pubmed | 2.90e-10 | 4 | 145 | 4 | 2423416 | ||
| Pubmed | 2.90e-10 | 4 | 145 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 2.90e-10 | 4 | 145 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 2.90e-10 | 4 | 145 | 4 | 2989529 | |
| Pubmed | 2.90e-10 | 4 | 145 | 4 | 6160849 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 2.90e-10 | 4 | 145 | 4 | 1141004 | |
| Pubmed | 2.90e-10 | 4 | 145 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 2.90e-10 | 4 | 145 | 4 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 2.90e-10 | 4 | 145 | 4 | 6207174 | |
| Pubmed | 2.90e-10 | 4 | 145 | 4 | 2410924 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 2.90e-10 | 4 | 145 | 4 | 2332419 | |
| Pubmed | 1.44e-09 | 5 | 145 | 4 | 6529441 | ||
| Pubmed | 1.44e-09 | 5 | 145 | 4 | 6176569 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 1.44e-09 | 5 | 145 | 4 | 34276419 | |
| Pubmed | 1.44e-09 | 5 | 145 | 4 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 1.44e-09 | 5 | 145 | 4 | 8661735 | |
| Pubmed | 2.28e-09 | 14 | 145 | 5 | 7894156 | ||
| Pubmed | 4.32e-09 | 6 | 145 | 4 | 2002257 | ||
| Pubmed | 4.32e-09 | 6 | 145 | 4 | 2450406 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 4.32e-09 | 6 | 145 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 4.32e-09 | 6 | 145 | 4 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 4.32e-09 | 6 | 145 | 4 | 9250879 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 4.32e-09 | 6 | 145 | 4 | 7859283 | |
| Pubmed | 4.32e-09 | 6 | 145 | 4 | 7946325 | ||
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 4.32e-09 | 6 | 145 | 4 | 1021597 | |
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 1.00e-08 | 7 | 145 | 4 | 1401878 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 1.00e-08 | 7 | 145 | 4 | 2451911 | |
| Pubmed | 1.00e-08 | 7 | 145 | 4 | 7949740 | ||
| Pubmed | 1.00e-08 | 7 | 145 | 4 | 6160178 | ||
| Pubmed | 1.00e-08 | 7 | 145 | 4 | 8604219 | ||
| Pubmed | 1.00e-08 | 7 | 145 | 4 | 8666240 | ||
| Pubmed | 1.00e-08 | 7 | 145 | 4 | 8034329 | ||
| Pubmed | 2.00e-08 | 8 | 145 | 4 | 2040456 | ||
| Pubmed | 2.00e-08 | 8 | 145 | 4 | 3038891 | ||
| Pubmed | 2.00e-08 | 8 | 145 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 2.00e-08 | 8 | 145 | 4 | 7523515 | |
| Pubmed | 2.00e-08 | 8 | 145 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 2.00e-08 | 8 | 145 | 4 | 6200103 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CFH AMY1A AMY1B AMY1C AMY2A AMY2B MYL6 APCS MUC5B CUBN FCGBP GLA HMCN1 PTPRS GLG1 MYL6B NECTIN4 C1R VCP ALPL | 2.24e-08 | 1070 | 145 | 20 | 23533145 |
| Pubmed | 3.59e-08 | 9 | 145 | 4 | 93520 | ||
| Pubmed | 5.97e-08 | 10 | 145 | 4 | 9121556 | ||
| Pubmed | 5.97e-08 | 10 | 145 | 4 | 2897103 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 32697825 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 19776007 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 33316546 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 7.10e-08 | 3 | 145 | 3 | 2413838 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 9038233 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 28704475 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 7.10e-08 | 3 | 145 | 3 | 21827821 | |
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 7.10e-08 | 3 | 145 | 3 | 6360562 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 7.10e-08 | 3 | 145 | 3 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 7.10e-08 | 3 | 145 | 3 | 22341088 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 32380082 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 23667648 | ||
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 7.10e-08 | 3 | 145 | 3 | 2436036 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 28877989 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 19800850 | ||
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 7.10e-08 | 3 | 145 | 3 | 6180955 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 38987795 | ||
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 7.10e-08 | 3 | 145 | 3 | 17223109 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 15299664 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 37105392 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 8413315 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 36479526 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 7.10e-08 | 3 | 145 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 7.10e-08 | 3 | 145 | 3 | 33923930 | |
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 7.10e-08 | 3 | 145 | 3 | 31969388 | |
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 7.10e-08 | 3 | 145 | 3 | 35241678 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 22063648 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 22627368 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 33153471 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 22052881 | ||
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 7.10e-08 | 3 | 145 | 3 | 7678001 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 7.10e-08 | 3 | 145 | 3 | 23408620 | |
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 7.10e-08 | 3 | 145 | 3 | 29458010 | |
| Cytoband | 1p21 | 1.19e-08 | 24 | 145 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 2.41e-05 | 107 | 145 | 5 | chr1p21 | |
| Cytoband | 10q22-q23 | 9.85e-05 | 5 | 145 | 2 | 10q22-q23 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.09e-06 | 161 | 100 | 8 | 593 | |
| GeneFamily | Galectins | 7.12e-05 | 15 | 100 | 3 | 629 | |
| GeneFamily | Immunoglobulin like domain containing | 9.82e-05 | 193 | 100 | 7 | 594 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.78e-04 | 57 | 100 | 4 | 1179 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 1.06e-03 | 9 | 100 | 2 | 973 | |
| GeneFamily | Fibronectin type III domain containing | 1.95e-03 | 160 | 100 | 5 | 555 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.10e-03 | 46 | 100 | 3 | 622 | |
| GeneFamily | Myosin light chains|EF-hand domain containing | 2.64e-03 | 14 | 100 | 2 | 657 | |
| GeneFamily | Potassium voltage-gated channel regulatory subunits|DASH family | 3.03e-03 | 15 | 100 | 2 | 858 | |
| GeneFamily | Dyneins, axonemal | 3.90e-03 | 17 | 100 | 2 | 536 | |
| Coexpression | NABA_MATRISOME | GPC1 LGALS9C PCSK5 IL12B COL11A2 LGALS9B WNT5A KCP CDCP2 RSPO4 MUC5B COLEC10 VWCE ADAM12 VWDE LGALS9 CRELD1 NELL2 HMCN1 ADAMTS15 SCUBE3 VWA3B LOXL3 NRG3 HCFC1 | 2.99e-10 | 1008 | 145 | 25 | MM17056 |
| Coexpression | NABA_MATRISOME | GPC1 LGALS9C PCSK5 IL12B COL11A2 LGALS9B WNT5A KCP CDCP2 RSPO4 MUC5B COLEC10 VWCE ADAM12 VWDE LGALS9 CRELD1 NELL2 HMCN1 ADAMTS15 SCUBE3 VWA3B LOXL3 NRG3 HCFC1 | 4.31e-10 | 1026 | 145 | 25 | M5889 |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | LGALS9C CFH KIF13B AMY1B AMY1C AMY2A AMY2B LGALS9B LGALS9 ZNF76 HERC1 | 9.96e-08 | 239 | 145 | 11 | MM1274 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.24e-06 | 191 | 145 | 9 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.54e-06 | 196 | 145 | 9 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 2.77e-06 | 270 | 145 | 10 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 3.26e-06 | 275 | 145 | 10 | M5884 | |
| Coexpression | MARKEY_RB1_CHRONIC_LOF_DN | 8.21e-06 | 130 | 145 | 7 | MM975 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | GPC1 LGALS9C PCSK5 IL12B LGALS9B WNT5A MUC5B COLEC10 ADAM12 LGALS9 ADAMTS15 SCUBE3 LOXL3 NRG3 HCFC1 | 1.55e-05 | 738 | 145 | 15 | MM17058 |
| Coexpression | GSE17721_POLYIC_VS_CPG_6H_BMDC_DN | 1.63e-05 | 200 | 145 | 8 | M3944 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | GPC1 LGALS9C PCSK5 IL12B LGALS9B WNT5A MUC5B COLEC10 ADAM12 LGALS9 ADAMTS15 SCUBE3 LOXL3 NRG3 HCFC1 | 1.90e-05 | 751 | 145 | 15 | M5885 |
| Coexpression | BERGER_MBD2_TARGETS | 2.65e-05 | 11 | 145 | 3 | MM905 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL | 4.78e-05 | 301 | 145 | 9 | M45708 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP | 7.19e-05 | 15 | 145 | 3 | M1619 | |
| Coexpression | LEE_AGING_MUSCLE_UP | 7.76e-05 | 41 | 145 | 4 | MM698 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 8.48e-05 | 187 | 145 | 7 | M6807 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 9.55e-05 | 132 | 145 | 6 | MM470 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | ROCK2 LGALS9C RB1 LGALS9B LGALS9 CRELD1 RPIA ZNF43 ADAMTS15 ZNF721 IFT122 HADHB VCP | 1.01e-04 | 675 | 145 | 13 | MM1073 |
| Coexpression | LIU_VAV3_PROSTATE_CARCINOGENESIS_DN | 1.07e-04 | 17 | 145 | 3 | M12393 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP | 1.07e-04 | 17 | 145 | 3 | MM686 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 1.21e-04 | 198 | 145 | 7 | M3171 | |
| Coexpression | GSE369_IFNG_KO_VS_WT_LIVER_DN | 1.29e-04 | 200 | 145 | 7 | M5972 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP | 1.29e-04 | 200 | 145 | 7 | M9944 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | CNTN4 SDK2 COL11A2 DNAH10 WNT5A KCP RSPO4 CUBN ADAM12 TH NELL2 HOXB9 TRIM67 CNTN5 SORCS2 SCUBE3 KCNIP4 VWA3B JPH3 | 3.16e-05 | 992 | 141 | 19 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | CNTN4 SDK2 DNAH10 RSPO4 ADAM12 HOXB9 TRIM67 HMCN1 CNTN5 SORCS2 SCUBE3 KCNIP4 | 3.31e-05 | 433 | 141 | 12 | Arv_EB-LF_1000_K4 |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.59e-07 | 195 | 145 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Club_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 5.45e-07 | 147 | 145 | 7 | 5a824c89e4d045af465d7333275f8191fb29b041 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 6.54e-07 | 151 | 145 | 7 | 4533bccc996395f74b16af939ce79b6fe253c073 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 6.54e-07 | 151 | 145 | 7 | edb2f59789c295838d2030b80c792cbea25eaa3d | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.83e-07 | 152 | 145 | 7 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.97e-06 | 178 | 145 | 7 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.04e-06 | 179 | 145 | 7 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-06 | 181 | 145 | 7 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-06 | 185 | 145 | 7 | 7f46ea82a663181957f88e4e83114aef8a78820c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-06 | 185 | 145 | 7 | 956fb0043c0c3e4e5c4d6f58ff95faf6209c380e | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 2.82e-06 | 188 | 145 | 7 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 2.92e-06 | 189 | 145 | 7 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.36e-06 | 193 | 145 | 7 | 8ede7038a222c7e7ecaf7e86520823cf606cbee7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.36e-06 | 193 | 145 | 7 | 0e7d7adfaa7191e34038fcda6677561ae13934eb | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 196 | 145 | 7 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 196 | 145 | 7 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.84e-06 | 197 | 145 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Sigmoid-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 3.97e-06 | 198 | 145 | 7 | 305d7ae9b070ac7211638a5282374c02bf13af40 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.97e-06 | 198 | 145 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.11e-06 | 199 | 145 | 7 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-9|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-05 | 151 | 145 | 6 | 2314c004434aed9b7fa1ad01c61c43e5ed4a18ce | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-05 | 154 | 145 | 6 | ec56b7fb88e39041416c384f371c767f3b4e92fa | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.37e-05 | 159 | 145 | 6 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-05 | 167 | 145 | 6 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.81e-05 | 167 | 145 | 6 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.01e-05 | 170 | 145 | 6 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | droplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 171 | 145 | 6 | 92ac4cc3d54da2ea8e202aa59c78e8875356649e | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 2.21e-05 | 173 | 145 | 6 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | Influenza_Severe-B_intermediate|Influenza_Severe / Disease group and Cell class | 2.29e-05 | 174 | 145 | 6 | 4276bdaac53aebd3084323a90ecde572d3177446 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 177 | 145 | 6 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-05 | 180 | 145 | 6 | f103e161e966c257eac97e1b30a461c4ed9cafc2 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.85e-05 | 181 | 145 | 6 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.94e-05 | 182 | 145 | 6 | ba066ff9029cc052b76e2330ec168cb2e9b7e498 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.94e-05 | 182 | 145 | 6 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.04e-05 | 183 | 145 | 6 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.04e-05 | 183 | 145 | 6 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 3.04e-05 | 183 | 145 | 6 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-05 | 184 | 145 | 6 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM4|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.13e-05 | 184 | 145 | 6 | 63ef6ba6ac33c3032735008ce3b411636ab3c395 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.13e-05 | 184 | 145 | 6 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-05 | 185 | 145 | 6 | e06a784a297f357f3f8e761c24fa70722048ab42 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.23e-05 | 185 | 145 | 6 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.23e-05 | 185 | 145 | 6 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-05 | 186 | 145 | 6 | ba6ba75218efc26371cea24ddbb0e9b3e3f421ac | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-05 | 186 | 145 | 6 | a58c9d1567da0961e0e295a156773d2252ee5a1a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-05 | 186 | 145 | 6 | 65e25a9dcef5fc71510aaf170e220deef5b2feb2 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.33e-05 | 186 | 145 | 6 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-05 | 186 | 145 | 6 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-05 | 186 | 145 | 6 | e4f1259725160719e5fd13d76e5a707efed70013 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 187 | 145 | 6 | 3e25c15fa29f8c738044914e8b3420d5713f18d9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 187 | 145 | 6 | 965584ee44669a72866a20ddf7f657bc5a7f7a8b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 187 | 145 | 6 | a7ef179e6561e17cafae10e1843bf82ac3ae0c89 | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|Mesenchymal_cells / Lineage and Cell class | 3.43e-05 | 187 | 145 | 6 | e899b906409f3fad69cb3d3c6432c3fd862ae3c1 | |
| ToppCell | 15-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 3.53e-05 | 188 | 145 | 6 | 9a64fb07de611de38d6f24673feb3b81a5e85384 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.53e-05 | 188 | 145 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.64e-05 | 189 | 145 | 6 | b06471b1bebb990d5146bddfb8002401c6b099a0 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.64e-05 | 189 | 145 | 6 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 189 | 145 | 6 | d00410010283dc6191ce9857d6c7952678fed588 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.64e-05 | 189 | 145 | 6 | a8246acf31f02c85421268245afb651aa8788f14 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 3.75e-05 | 190 | 145 | 6 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.75e-05 | 190 | 145 | 6 | 1307688255a1250fa300edf2c41f1affe31dcc98 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.75e-05 | 190 | 145 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.86e-05 | 191 | 145 | 6 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 3.97e-05 | 192 | 145 | 6 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.97e-05 | 192 | 145 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.97e-05 | 192 | 145 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.97e-05 | 192 | 145 | 6 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | 11.5-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 4.09e-05 | 193 | 145 | 6 | d4779d92a4dd4b8b656383e6f4fce76d3bd70931 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 4.09e-05 | 193 | 145 | 6 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 4.09e-05 | 193 | 145 | 6 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 4.09e-05 | 193 | 145 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.09e-05 | 193 | 145 | 6 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 4.21e-05 | 194 | 145 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 4.21e-05 | 194 | 145 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.21e-05 | 194 | 145 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.21e-05 | 194 | 145 | 6 | 811b382ec3da06a6bda7360abc8b633f96b2019e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.21e-05 | 194 | 145 | 6 | 292ce9021678534c9eedb367b9772a9d976208a8 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 4.21e-05 | 194 | 145 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | normal_Lung-Epithelial_cells-Club|normal_Lung / Location, Cell class and cell subclass | 4.33e-05 | 195 | 145 | 6 | b46544ad5af04f4dbc2643637caa3d2d50d922ae | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.33e-05 | 195 | 145 | 6 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.45e-05 | 196 | 145 | 6 | 784459f9f3614ead947aeb61a873dfd4cbe50641 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.45e-05 | 196 | 145 | 6 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.58e-05 | 197 | 145 | 6 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.58e-05 | 197 | 145 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.58e-05 | 197 | 145 | 6 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | distal-mesenchymal-Lipofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.58e-05 | 197 | 145 | 6 | 865010edcd7e3f79f505fcef7b33882095994aa8 | |
| ToppCell | Severe-Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.58e-05 | 197 | 145 | 6 | 1089aa7991812378668d0f3d57f8000e6245a713 | |
| ToppCell | distal-mesenchymal-Lipofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.58e-05 | 197 | 145 | 6 | ceb83bdef16b58ee16193413bfb006f7715728b2 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.58e-05 | 197 | 145 | 6 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.58e-05 | 197 | 145 | 6 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.58e-05 | 197 | 145 | 6 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.58e-05 | 197 | 145 | 6 | a07ab2564ca7d577fd47f444dd7b0c25556e9fc4 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.58e-05 | 197 | 145 | 6 | fb50903b87498b400c8e16e6a561b6d9458e5d97 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.58e-05 | 197 | 145 | 6 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.71e-05 | 198 | 145 | 6 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.71e-05 | 198 | 145 | 6 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.71e-05 | 198 | 145 | 6 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.71e-05 | 198 | 145 | 6 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.71e-05 | 198 | 145 | 6 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.71e-05 | 198 | 145 | 6 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| Drug | R 623 | 5.63e-11 | 6 | 144 | 5 | CID003027594 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 5.63e-11 | 6 | 144 | 5 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 5.63e-11 | 6 | 144 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 5.63e-11 | 6 | 144 | 5 | CID000127364 | |
| Drug | CNP-G3 | 5.63e-11 | 6 | 144 | 5 | CID003082910 | |
| Drug | AC1L5BOU | 1.96e-10 | 7 | 144 | 5 | CID000174858 | |
| Drug | BG5P | 1.96e-10 | 7 | 144 | 5 | CID003082752 | |
| Drug | AC1NSVJM | 5.21e-10 | 8 | 144 | 5 | CID005317411 | |
| Drug | desethylaprophen | 5.21e-10 | 8 | 144 | 5 | CID000163919 | |
| Drug | azintamide | 5.21e-10 | 8 | 144 | 5 | CID000071105 | |
| Drug | alpha-maltosyl fluoride | 1.17e-09 | 9 | 144 | 5 | CID000194237 | |
| Drug | trestatin A | 1.17e-09 | 9 | 144 | 5 | CID003054994 | |
| Drug | N-PMT | 1.53e-09 | 4 | 144 | 4 | CID000194224 | |
| Drug | AC1MQT4V | 1.53e-09 | 4 | 144 | 4 | CID003482066 | |
| Drug | SAIB-SG | 1.53e-09 | 4 | 144 | 4 | CID002735139 | |
| Drug | 2-nitropropyl acetate | 1.53e-09 | 4 | 144 | 4 | CID013573844 | |
| Drug | Dembrexine | 1.53e-09 | 4 | 144 | 4 | CID000072009 | |
| Drug | g lw | 1.53e-09 | 4 | 144 | 4 | CID000444139 | |
| Drug | beta-santalene | 1.53e-09 | 4 | 144 | 4 | CID000010534 | |
| Drug | AC1LAC07 | 2.32e-09 | 10 | 144 | 5 | CID000485275 | |
| Drug | Glc)4 | 2.32e-09 | 10 | 144 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 2.32e-09 | 10 | 144 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 2.32e-09 | 10 | 144 | 5 | CID000118008 | |
| Drug | validamycin D | 4.23e-09 | 11 | 144 | 5 | CID000166726 | |
| Drug | FG5P | 4.23e-09 | 11 | 144 | 5 | CID000127486 | |
| Drug | CNP-G5 | 4.23e-09 | 11 | 144 | 5 | CID000127309 | |
| Drug | HgI2 | 4.23e-09 | 11 | 144 | 5 | CID000024485 | |
| Drug | 2C KM | 4.23e-09 | 11 | 144 | 5 | CID009549196 | |
| Drug | azaprophen | 7.21e-09 | 12 | 144 | 5 | CID000129486 | |
| Drug | Deposiston | 7.64e-09 | 5 | 144 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 7.64e-09 | 5 | 144 | 4 | CID010358258 | |
| Drug | lunularic acid | 7.64e-09 | 5 | 144 | 4 | CID000161413 | |
| Drug | himachalene | 7.64e-09 | 5 | 144 | 4 | CID000015095 | |
| Drug | actinidine | 7.64e-09 | 5 | 144 | 4 | CID000068231 | |
| Drug | 2TAA | 7.64e-09 | 5 | 144 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 7.64e-09 | 5 | 144 | 4 | CID006449879 | |
| Drug | silver perchlorate | 7.64e-09 | 5 | 144 | 4 | CID000024562 | |
| Drug | AC1L4DZ4 | 7.64e-09 | 5 | 144 | 4 | CID000155287 | |
| Drug | methyl 1'-epiacarviosin | 1.17e-08 | 13 | 144 | 5 | CID000197426 | |
| Drug | isoacarbose | 1.17e-08 | 13 | 144 | 5 | CID000449165 | |
| Drug | Cyclodextrins | 1.80e-08 | 14 | 144 | 5 | CID000024238 | |
| Drug | 2-chloro-4-nitrophenol | 1.80e-08 | 14 | 144 | 5 | CID000012074 | |
| Drug | terephthaloyl chloride | 1.80e-08 | 14 | 144 | 5 | CID000007488 | |
| Drug | 2-amino-6-picoline | 2.28e-08 | 6 | 144 | 4 | CID000015765 | |
| Drug | phenol blue | 2.28e-08 | 6 | 144 | 4 | CID000075078 | |
| Drug | Gu-4 | 2.28e-08 | 6 | 144 | 4 | CID000448679 | |
| Drug | Borane dimethylamine complex | 2.28e-08 | 6 | 144 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 2.28e-08 | 6 | 144 | 4 | CID000092801 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 2.28e-08 | 6 | 144 | 4 | CID009577343 | |
| Drug | AC1OAGH8 | 2.28e-08 | 6 | 144 | 4 | CID006857368 | |
| Drug | vermella | 2.28e-08 | 6 | 144 | 4 | CID000203726 | |
| Drug | hymenin | 2.28e-08 | 6 | 144 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 2.28e-08 | 6 | 144 | 4 | CID000011615 | |
| Drug | R B I | 2.43e-08 | 29 | 144 | 6 | CID003423208 | |
| Drug | 4-nitrophenylmaltoheptaoside | 2.69e-08 | 15 | 144 | 5 | CID000173254 | |
| Drug | gamma-cyclodextrin | 3.90e-08 | 16 | 144 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 3.90e-08 | 16 | 144 | 5 | CID003085308 | |
| Drug | Alfadexum | 4.83e-08 | 54 | 144 | 7 | CID000024796 | |
| Drug | methyl blue | 5.29e-08 | 7 | 144 | 4 | CID011969534 | |
| Drug | 3KBG5CNP | 5.29e-08 | 7 | 144 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 5.29e-08 | 7 | 144 | 4 | CID000071762 | |
| Drug | Paramax | 5.29e-08 | 7 | 144 | 4 | CID000156411 | |
| Drug | amino-methyl | 5.29e-08 | 7 | 144 | 4 | CID000142005 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 5.57e-08 | 83 | 144 | 8 | CID011968896 | |
| Drug | trimitan | 7.57e-08 | 18 | 144 | 5 | CID000005561 | |
| Drug | sucrose-6-phosphate | 7.57e-08 | 18 | 144 | 5 | CID000644101 | |
| Drug | aprophen | 7.57e-08 | 18 | 144 | 5 | CID000071128 | |
| Drug | AC1L9MQJ | 1.02e-07 | 19 | 144 | 5 | CID000449108 | |
| Drug | boric acid gel | 1.05e-07 | 8 | 144 | 4 | CID003016474 | |
| Drug | N-vinylcaprolactam | 1.05e-07 | 8 | 144 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 1.05e-07 | 8 | 144 | 4 | CID000146692 | |
| Drug | acrinor | 1.05e-07 | 8 | 144 | 4 | CID005489637 | |
| Drug | NSC300622 | 1.05e-07 | 8 | 144 | 4 | CID000028426 | |
| Drug | theodrenaline | 1.05e-07 | 8 | 144 | 4 | CID000071857 | |
| Drug | rhodanile blue | 1.05e-07 | 8 | 144 | 4 | CID000073372 | |
| Drug | neotrehalose | AMY1A AMY1B AMY1C COL11A2 AMY2A AMY2B IFT57 SGTA APCS TH JPH3 | 1.23e-07 | 214 | 144 | 11 | CID000001143 |
| Drug | AC1L3XPY | 1.77e-07 | 21 | 144 | 5 | CID000124005 | |
| Drug | GSAD | 1.89e-07 | 9 | 144 | 4 | CID009909127 | |
| Drug | GU-3 | 1.89e-07 | 9 | 144 | 4 | CID000448687 | |
| Drug | zingiberene | 1.89e-07 | 9 | 144 | 4 | CID000092776 | |
| Drug | Atonik | 1.89e-07 | 9 | 144 | 4 | CID000069471 | |
| Drug | H 187 | 1.89e-07 | 9 | 144 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 1.89e-07 | 9 | 144 | 4 | CID000024864 | |
| Drug | maltosaccharide | 2.28e-07 | 22 | 144 | 5 | CID005461034 | |
| Drug | STA2 | 2.46e-07 | 68 | 144 | 7 | CID005311453 | |
| Drug | AC1N3UXZ | 2.48e-07 | 3 | 144 | 3 | CID004118625 | |
| Drug | I ZE | 3.13e-07 | 10 | 144 | 4 | CID009549200 | |
| Drug | trans-cinnamamide | 3.13e-07 | 10 | 144 | 4 | CID000012135 | |
| Drug | CG-120 | 3.13e-07 | 10 | 144 | 4 | CID000171403 | |
| Drug | eicosa-11,14-dienoic acid | 3.13e-07 | 10 | 144 | 4 | CID000003208 | |
| Drug | UDP-pyridoxal | 3.13e-07 | 10 | 144 | 4 | CID000126789 | |
| Drug | naphthalene-1,3,6,8-tetrol | 3.13e-07 | 10 | 144 | 4 | CID000440202 | |
| Drug | Panose B | 3.64e-07 | 24 | 144 | 5 | CID000439297 | |
| Drug | CID439354 | 4.53e-07 | 25 | 144 | 5 | CID000439354 | |
| Drug | Tempamine | 4.89e-07 | 11 | 144 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 4.89e-07 | 11 | 144 | 4 | CID000164608 | |
| Drug | AMO-1618 | 4.89e-07 | 11 | 144 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 4.89e-07 | 11 | 144 | 4 | CID000430710 | |
| Drug | CaCl2 | 6.83e-07 | 156 | 144 | 9 | CID000024854 | |
| Drug | chloroisocyanuric acid | 7.30e-07 | 12 | 144 | 4 | CID000017921 | |
| Disease | alpha-amylase 1 measurement | 6.00e-08 | 9 | 140 | 4 | EFO_0801371 | |
| Disease | Hypophosphatasia | 2.24e-05 | 2 | 140 | 2 | C0020630 | |
| Disease | Disproportionate short stature | 3.36e-05 | 77 | 140 | 5 | C0878659 | |
| Disease | Benign neoplasm of bladder | 4.56e-05 | 15 | 140 | 3 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 4.56e-05 | 15 | 140 | 3 | C0154091 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 4.56e-05 | 15 | 140 | 3 | C0496930 | |
| Disease | Malignant neoplasm of breast | GPC1 RB1 STRBP ROR1 APCS CUBN ADAM12 CLIP1 HOXB9 TRMT2A OTOF ICAM5 NISCH HADHB REPS2 DNMT1 | 5.30e-05 | 1074 | 140 | 16 | C0006142 |
| Disease | R-spondin-4 measurement | 6.68e-05 | 3 | 140 | 2 | EFO_0022019 | |
| Disease | serine/threonine-protein kinase receptor R3 measurement | 6.68e-05 | 3 | 140 | 2 | EFO_0020733 | |
| Disease | 4-hydroxyphenylacetylglutamine measurement | 6.68e-05 | 3 | 140 | 2 | EFO_0800688 | |
| Disease | Carcinoma of bladder | 8.10e-05 | 18 | 140 | 3 | C0699885 | |
| Disease | BLADDER CANCER | 1.33e-04 | 4 | 140 | 2 | 109800 | |
| Disease | Malignant tumor of urinary bladder | 1.33e-04 | 4 | 140 | 2 | cv:C0005684 | |
| Disease | Multiple Mitochondrial Dysfunctions Syndrome | 1.33e-04 | 4 | 140 | 2 | C3502075 | |
| Disease | receptor tyrosine-protein kinase erbb-3 measurement | 1.33e-04 | 4 | 140 | 2 | EFO_0020701 | |
| Disease | natural killer cell receptor 2B4 measurement | 1.33e-04 | 4 | 140 | 2 | EFO_0021882 | |
| Disease | Colorectal Carcinoma | CNTN4 ERCC2 FPGS CUBN P2RX7 ZNF43 PTPRS ICAM5 ADAMTS15 FGFR3 JPH3 ZNF292 | 1.36e-04 | 702 | 140 | 12 | C0009402 |
| Disease | complement factor H-like 1 protein measurement | 1.51e-04 | 22 | 140 | 3 | EFO_0600092 | |
| Disease | fibroblast growth factor receptor 3 measurement | 2.21e-04 | 5 | 140 | 2 | EFO_0020390 | |
| Disease | galectin-1 measurement | 2.21e-04 | 5 | 140 | 2 | EFO_0020932 | |
| Disease | galectin-9 measurement | 2.21e-04 | 5 | 140 | 2 | EFO_0021863 | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 2.51e-04 | 26 | 140 | 3 | EFO_0005325, EFO_0005532, EFO_0010735 | |
| Disease | collagen alpha-2(XI) chain measurement | 3.31e-04 | 6 | 140 | 2 | EFO_0801490 | |
| Disease | indoleacetylglutamine measurement | 3.31e-04 | 6 | 140 | 2 | EFO_0800035 | |
| Disease | amyloid beta A4 precursor protein-binding family B member 2 measurement | 3.31e-04 | 6 | 140 | 2 | EFO_0801379 | |
| Disease | nischarin measurement | 3.31e-04 | 6 | 140 | 2 | EFO_0801841 | |
| Disease | clusterin measurement | 4.62e-04 | 7 | 140 | 2 | EFO_0007655 | |
| Disease | r-spondin-3 measurement | 4.62e-04 | 7 | 140 | 2 | EFO_0021878 | |
| Disease | Bipolar Disorder | 4.73e-04 | 477 | 140 | 9 | C0005586 | |
| Disease | urinary bladder cancer (is_implicated_in) | 4.78e-04 | 76 | 140 | 4 | DOID:11054 (is_implicated_in) | |
| Disease | primary dental caries | 5.62e-04 | 34 | 140 | 3 | EFO_0600095 | |
| Disease | lymphocyte count | ROCK2 ZAN DNAH10 RB1 STRBP COLEC10 ACVRL1 KLHL29 ZFP36L1 ICAM5 CNTN5 KIRREL1 CD79B DDHD2 RNF39 DNMT1 RBM17 | 5.89e-04 | 1464 | 140 | 17 | EFO_0004587 |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 1 | 6.14e-04 | 8 | 140 | 2 | C0020071 | |
| Disease | Acute erythroleukemia - M6a subtype | 6.14e-04 | 8 | 140 | 2 | C2930975 | |
| Disease | Acute myeloid leukemia FAB-M6 | 6.14e-04 | 8 | 140 | 2 | C2930976 | |
| Disease | Acute erythroleukemia - M6b subtype | 6.14e-04 | 8 | 140 | 2 | C2930977 | |
| Disease | Acute erythroleukemia | 6.14e-04 | 8 | 140 | 2 | C2930974 | |
| Disease | FEV/FEC ratio | PCSK5 STRBP ADAM12 CRELD1 NELL2 FCGBP HMCN1 CEP72 CNTN5 SCUBE3 FGFR3 HERC1 KIF13A DNAH5 JPH3 | 7.55e-04 | 1228 | 140 | 15 | EFO_0004713 |
| Disease | collectin-10 measurement | 7.87e-04 | 9 | 140 | 2 | EFO_0801491 | |
| Disease | f-box/LRR-repeat protein 4 measurement | 9.81e-04 | 10 | 140 | 2 | EFO_0802538 | |
| Disease | uremia (biomarker_via_orthology) | 9.81e-04 | 10 | 140 | 2 | DOID:4676 (biomarker_via_orthology) | |
| Disease | type 1 diabetes mellitus | 1.08e-03 | 242 | 140 | 6 | MONDO_0005147 | |
| Disease | response to bronchodilator, FEV/FEC ratio | CFH CNTN4 SDK2 THSD7A RB1 ROR1 CNTN5 KCNIP4 HERC3 DNAH5 JPH3 | 1.10e-03 | 766 | 140 | 11 | EFO_0004713, GO_0097366 |
| Disease | tumor necrosis factor receptor superfamily member 11B measurement | 1.20e-03 | 11 | 140 | 2 | EFO_0020801 | |
| Disease | hearing impairment | 1.24e-03 | 98 | 140 | 4 | C1384666 | |
| Disease | reticulocyte count | DNAH10 BAG5 CLIP1 PPIF TMX2 SUSD1 ZFP36L1 NISCH CNTN5 HERC1 RNF39 VDAC2 DNMT1 | 1.45e-03 | 1045 | 140 | 13 | EFO_0007986 |
| Disease | tumor necrosis factor ligand superfamily member 11 measurement | 1.68e-03 | 13 | 140 | 2 | EFO_0010617 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 1.68e-03 | 13 | 140 | 2 | C0369183 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 1.68e-03 | 13 | 140 | 2 | C1261502 | |
| Disease | Ciliopathies | 1.90e-03 | 110 | 140 | 4 | C4277690 | |
| Disease | complement factor H measurement, protein binding measurement | 1.96e-03 | 14 | 140 | 2 | EFO_0008097, EFO_0010742 | |
| Disease | Colorectal Neoplasms | 2.13e-03 | 277 | 140 | 6 | C0009404 | |
| Disease | hair morphology measurement | 2.17e-03 | 54 | 140 | 3 | EFO_0007821 | |
| Disease | Situs ambiguus | 2.25e-03 | 15 | 140 | 2 | C0266642 | |
| Disease | low density lipoprotein cholesterol measurement, response to selective serotonin reuptake inhibitor | 2.25e-03 | 15 | 140 | 2 | EFO_0004611, EFO_0005658 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 2.25e-03 | 15 | 140 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | dual specificity mitogen-activated protein kinase kinase 2 measurement | 2.57e-03 | 16 | 140 | 2 | EFO_0008112 | |
| Disease | C-X-C motif chemokine 6 measurement | 2.57e-03 | 16 | 140 | 2 | EFO_0008059 | |
| Disease | Brachycephaly | 2.90e-03 | 17 | 140 | 2 | C0221356 | |
| Disease | SLAM family member 7 measurement | 2.90e-03 | 17 | 140 | 2 | EFO_0008287 | |
| Disease | Age-related macular degeneration | 3.25e-03 | 18 | 140 | 2 | cv:C0242383 | |
| Disease | Usual Interstitial Pneumonia | 3.63e-03 | 19 | 140 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 3.63e-03 | 19 | 140 | 2 | C4721508 | |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 3.63e-03 | 19 | 140 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 3.63e-03 | 19 | 140 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | anorectal malformation | 3.63e-03 | 19 | 140 | 2 | MONDO_0019938 | |
| Disease | squamous cell carcinoma (is_marker_for) | 3.63e-03 | 19 | 140 | 2 | DOID:1749 (is_marker_for) | |
| Disease | Mammary Carcinoma, Human | 3.68e-03 | 525 | 140 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.68e-03 | 525 | 140 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 3.76e-03 | 527 | 140 | 8 | C1458155 | |
| Disease | unipolar depression, memory performance, cognitive function measurement | 4.02e-03 | 20 | 140 | 2 | EFO_0003761, EFO_0004874, EFO_0008354 | |
| Disease | polymyositis | 4.02e-03 | 20 | 140 | 2 | EFO_0003063 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 4.02e-03 | 20 | 140 | 2 | C4721952 | |
| Disease | Breast Carcinoma | 4.25e-03 | 538 | 140 | 8 | C0678222 | |
| Disease | Idiopathic Pulmonary Fibrosis | 4.42e-03 | 21 | 140 | 2 | C1800706 | |
| Disease | in situ carcinoma (is_marker_for) | 4.42e-03 | 21 | 140 | 2 | DOID:8719 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| REKIVPFYNGGNCVT | 106 | Q9UL15 | |
| QFTCNEGYDLQGSKR | 366 | Q7Z408 | |
| VDFKAVQGRCTVEYG | 1051 | P26358 | |
| FSAGYQKDVCGGVLT | 136 | Q5VXM1 | |
| NPNGRFVVVCGDGEY | 361 | P35606 | |
| YFGQEGMTEVQCGKV | 496 | Q96KE9 | |
| GEGSYGVVFKCRNKT | 11 | Q5MAI5 | |
| NGVSFTKGCYIGQEL | 251 | Q5T440 | |
| AGTYCDVISGDKING | 461 | P0DTE7 | |
| AGTYCDVISGDKING | 461 | P0DTE8 | |
| GLYECVAENSRGKNV | 291 | Q8IWV2 | |
| QVALVECVGKGRYGE | 201 | P37023 | |
| GCGDNVVQAVEQYAK | 1531 | Q9UKA4 | |
| SFGGQKCGNRFVEEG | 421 | O43184 | |
| CAVVDGIQYKTGLGQ | 131 | Q96M93 | |
| LGIYADVGNKTCAGF | 131 | P06280 | |
| GTVCDCGRYRKFVGQ | 116 | Q9Y6Z7 | |
| AGTYCDVISGDKING | 461 | P0DUB6 | |
| VQYQCGDSGKQGRET | 241 | Q9P209 | |
| GQAVRFVCNSGYKIE | 171 | P08603 | |
| AGTYCDVISGDKING | 461 | P19961 | |
| QIYANGKNIGEFCGK | 256 | P00736 | |
| GIRFEDNGIYFCQQK | 111 | P40259 | |
| RKEGGQYGLVAACAA | 446 | P55084 | |
| GDKQETAINIGYSCR | 706 | Q9NTI2 | |
| GKSFREEQCEAFNGY | 576 | Q8TE58 | |
| EGKYVCRGENVFGSA | 546 | O94779 | |
| DYIKADGQNIGCRFP | 186 | Q14627 | |
| QGFEYKRVAGQCCGE | 5571 | Q9HC84 | |
| GGCQQNIGDRYFLKA | 31 | P25791 | |
| QGCVEIGSQRYKLGV | 436 | P06400 | |
| NSYGQCGRKVVENEI | 201 | Q96I51 | |
| AGTYCDVISGDKING | 461 | P04746 | |
| EGYQGVRCDQFLPKT | 321 | P56975 | |
| AYKFRVAGINACGRG | 1861 | P51610 | |
| YEVCLAGGSGTNEFK | 751 | Q9Y5F0 | |
| GENKQCENTEGGYRC | 316 | Q96HD1 | |
| EVAAVERKGGYNQLC | 181 | Q8IVH8 | |
| RYECANFGEQGITVG | 651 | P58215 | |
| QGFVVGYNGSKIFCL | 591 | Q9HBG6 | |
| DYCEGGDLFKRINAQ | 81 | Q96PY6 | |
| KSICQFQGRTYFEGE | 331 | Q99435 | |
| GLSTGCKVYANIGED | 426 | Q86T24 | |
| SCGEVRQIYGAKGFS | 31 | P35052 | |
| EDGEVYTCGLNTKGQ | 51 | Q15034 | |
| FEDGGYVVCNTRQKG | 66 | Q6DKI2 | |
| FEDGGYVVCNTRQKG | 66 | Q3B8N2 | |
| FEDGGYVVCNTRQNG | 66 | O00182 | |
| FYIVKENRGNEGTCV | 2076 | Q15751 | |
| RTGDGKILYSQCGDV | 21 | P60660 | |
| GEYRVGEGEKFNCEK | 1656 | Q92824 | |
| GTYRCKAANDQGEAV | 466 | Q9UMF0 | |
| YRGFKNECPSGVVNE | 91 | Q6PIL6 | |
| YRGFKNECPSGIVNE | 111 | Q9NS61 | |
| YVKEFRDGCQTQQGR | 1681 | P13942 | |
| QLEEAYSSGKGCNGR | 66 | O94830 | |
| ACQSYFDAVVVGGEQ | 146 | Q8TBE9 | |
| HQCTGRGAYKVQVEG | 556 | A0A1B0GTW7 | |
| AQCVGRAIRGKTDYG | 661 | P18074 | |
| TIQVKEFGDAGQYTC | 76 | P29460 | |
| RLQVEGGGCSGFQYK | 71 | Q86U28 | |
| VPQYGGRKCEGSDVQ | 4731 | Q96RW7 | |
| QGKYECVATNSAGVR | 211 | Q13332 | |
| KCGDNGSIVGRNQSY | 6 | A8MWK0 | |
| QRPGYGDNKICEGSE | 151 | P17482 | |
| YGECGQGFSVKSDVI | 526 | Q9NQV7 | |
| AYLCGVKANEGTVGV | 116 | P05186 | |
| GIQTGRCVVYEGNQK | 146 | Q99572 | |
| QGRGFKAEYRQTCEN | 1266 | O60494 | |
| NTQAGEGRVYKCLFN | 326 | Q92896 | |
| SEAKERYQQGNGGVT | 326 | Q9NWB7 | |
| QEGQAKNTYGTGCFL | 271 | Q14410 | |
| IGEGSYGVVFKCRNR | 11 | Q00532 | |
| AGGQDNVMGVKYCFR | 111 | O00311 | |
| GRKFDFQGTCNYVLA | 1686 | Q9Y6R7 | |
| DGRKFDFQGTCNYVL | 2886 | Q9Y6R7 | |
| ANNGVCGVGVAYNAR | 206 | P09958 | |
| QKGALQGYRDAVCSG | 256 | Q9BZC7 | |
| GSVGDALGYRNVCKE | 11 | Q8NDY3 | |
| IEKYCRVNGGFSGVK | 561 | O60476 | |
| VGIGGAYDCTNIIRK | 201 | Q05932 | |
| QYAVRGDGGKVECFI | 401 | Q96J84 | |
| SDRGNYTCVVENKFG | 221 | P22607 | |
| GTTYSCVGVFKNGRV | 36 | P11021 | |
| DELNIRQCTGTFGYG | 1781 | Q8IVF4 | |
| NRQCGGELGEFTGYI | 801 | Q8IX30 | |
| YQFRLCAVNDVGKGQ | 661 | Q58EX2 | |
| CEQQQKDGTFAAGGY | 301 | Q9HBR0 | |
| VYQGKGCQGSADHVV | 16 | Q9BZW8 | |
| GTGFLAYRFGQEQCV | 2151 | Q8TDX9 | |
| IQQEVIKAYGFSCDG | 61 | Q99622 | |
| GKNDGAVAGTRYFQC | 251 | P30622 | |
| YNIETAKRVCGNVAG | 3391 | Q8TE73 | |
| GYVKCDVAVVGKGDN | 371 | Q9HC10 | |
| RGADKSISYGGCVVQ | 86 | P59922 | |
| CLGEGILEKAFQGYN | 81 | Q9H1H9 | |
| GGCLTQEKIVAGYAS | 176 | P49247 | |
| KNDGSIGGKQYFRCN | 1741 | Q9NQT8 | |
| DGTVYNIGNCFGKNF | 186 | Q16518 | |
| QTEYRNKCEFLVGVG | 236 | Q8IZ69 | |
| GYFGIRGQEVNRCKK | 76 | Q2I0M5 | |
| SKLGNYAGAVQDCER | 136 | O43765 | |
| GGGIQTREVYCVQAN | 456 | Q9UPZ6 | |
| GCLYQGKEFASGERF | 726 | Q6ZWJ8 | |
| NVCIFAYGQTGAGKT | 521 | Q9BVG8 | |
| GYRKVVSNVCEGGVD | 751 | Q96PQ0 | |
| CFTIENKTPQGREYG | 96 | Q7KZF4 | |
| ENYSKDQGGRTLCGV | 71 | Q96SI9 | |
| ENFRALCTGEKGFGY | 76 | P30405 | |
| NASGCGEQINYGRVE | 66 | P34969 | |
| KVECGDFYNTGDRGK | 441 | Q08AH1 | |
| YGQTETVLICGNFKG | 376 | Q53FZ2 | |
| KEGGRQVICVYTDDF | 206 | Q9H3H3 | |
| TGYFQCVATNGKEVV | 126 | Q01973 | |
| CTGLNFGKVDVGRYT | 186 | Q9Y320 | |
| ITELGNAGFCDVQKY | 926 | Q8N2E2 | |
| GYNDCEKSFLQRGGL | 211 | Q8N184 | |
| GGGQVNSSRYKTELC | 106 | Q07352 | |
| GGQFREVYVGKETLC | 556 | Q6ZTA4 | |
| EECGKAFNRGSYLTQ | 351 | Q8TB69 | |
| FDRVGDGKILYSQCG | 76 | P14649 | |
| GVVLDKTCFYAEQGG | 526 | P49588 | |
| QITELCGAKRVGYFG | 91 | Q8NFH8 | |
| VLGQEQDSYGGKFDR | 151 | P02743 | |
| VGYDDIGGCRKQLAQ | 201 | P55072 | |
| ANGCVANGEVRNGYV | 16 | O15270 | |
| DLNGRYFGGRVVKAC | 371 | Q96I25 | |
| YGFVGNGRTQCVDKN | 61 | Q6UWL2 | |
| EECGKAFGRYTDLNQ | 576 | Q8TF20 | |
| FYKVAGGCQERSQGC | 841 | Q9Y2I1 | |
| FTGCGKVYRSQGELE | 811 | O60281 | |
| DCNYEGRKVANGQVF | 686 | Q96DN2 | |
| NDGTEFGGSIYQKVC | 196 | P45880 | |
| VLKSQGGDGFYGREC | 261 | O75116 | |
| GRGYDQFKTVQTERC | 341 | P41221 | |
| EFIYGGCEGNQNRFE | 81 | P10646 | |
| VDECKVHRGGYNGFN | 121 | P17038 | |
| GVNYVHQFCVGAAKG | 1711 | A7E2V4 | |
| NGETLYEQKQCGRAF | 111 | P58317 | |
| KGQKVIARCDENGFY | 1036 | Q502W6 | |
| KGQQVGDRAFRCGYK | 156 | P36508 | |
| YAVGAAGESVQRKGC | 311 | Q9H2S5 | |
| EGLVSGLCGNYDKNR | 2461 | Q9Y493 | |
| EFGLCKQNGEVKAYG | 406 | P07101 | |
| TVCGGKIYVFGGVNE | 726 | Q96CT2 | |
| FKGRYGVRECAGNGA | 91 | Q8WXH2 | |
| GVRECAGNGAKYEGT | 96 | Q8WXH2 | |
| KNVGGRYELAFGNCR | 141 | Q86YQ2 | |
| PCFYRGDSGEQVGQV | 51 | Q96NY8 |